CSG's Polish Artillery Push: A €100 Million Signal of Deeper Supply-Chain Ties
Published on 08/11/2026 at 23:41 | Redaktion boerse-global.de
The Dutch defence group CSG has quietly cemented its position in one of Europe's most strategically important munitions supply chains. Through its Polish subsidiary CSG Polska, the company signed a contract with Dezamet — a unit of the state-controlled PGZ group — valued at more than €100 million. The deal, inked on 24 July but only made public this week, covers pyrotechnic components and sub-assemblies for fuzes used in 155-mm artillery shells.
The significance extends well beyond the headline figure. The deliveries are designed to enable series production of ammunition for the Krab howitzer, a self-propelled artillery system currently fielded by the Polish army. Both companies point to a longstanding relationship that has already involved technology transfer, and this latest order slots into a broader framework agreement between PGZ-Amunicja and Polish suppliers worth roughly 11 billion zloty spanning 2024 to 2029.
The SAFE Backdrop
What makes this contract particularly notable is the financing environment surrounding it. In late May, Poland launched an additional programme exceeding 13.5 billion zloty, backed by the EU's SAFE defence credit initiative. That programme has stirred political debate in Warsaw, with Prime Minister Donald Tusk defending it in February as a reinforcement of national sovereignty and the domestic defence industrial base. According to Tusk, more than 80 percent of SAFE funds flow to Polish companies, while Germany's industry receives a mere 0.37 percent share.
Roughly 12,000 Polish firms are expected to benefit from the programme, which extends beyond ammunition to satellite technology, cyber defence, drone-countermeasure systems and the so-called Eastern Shield along the border. For CSG, already an established supplier to Poland's defence sector, the programme creates a favourable funding environment for follow-on orders that could stretch well beyond the current contract.
While CSG's expansion is built on securing supply chains for critical components, many businesses overlook a more basic vulnerability: workplace safety. A free toolkit with 41 ready-to-use templates and checklists helps you document risks properly and protect your workforce. Download the free Risk Assessment Toolkit
A Broader Expansion Spree
The Dezamet deal is far from an isolated move. Just days earlier, on 5 August, CSG acquired a minority stake in North Vector Dynamics Inc., a Canadian specialist in precision interception and hypersonic technologies. The company declined to disclose the size of the stake, describing it as a strategic investment in next-generation air defence. The day before, a CSG subsidiary reportedly acquired an industrial site in Germany, part of a strategy to broaden manufacturing and technology capabilities across multiple continents.
The corporate governance side has also seen movement. Ben Hudson joined the board as vice-chairman with effect from 1 August, having previously served as CEO of the Land Systems division and the group's technology chief — a move that underscores the tight coupling between operational leadership and oversight at CSG.
The Numbers Behind the Ambition
These expansionary steps rest on a solid financial foundation. CSG reported first-half revenue of €3.251 billion, up 17.2 percent year-on-year, and confirmed its full-year guidance. The order book, including projects under negotiation, climbed to €46 billion, with Land Systems contributing the largest share. The Defence Systems division grew revenue by 27.0 percent, posting operating EBIT of €784 million at a 24.1 percent margin.
But the balance sheet tells a more cautious story. Net debt rose to €2.914 billion, pushing the ratio to operating EBITDA over the trailing twelve months to 1.6 times — above the company's own year-end target of below 1.3 times. CSG attributed an operating cash flow of minus €411 million before taxes to strategic stockpiling of components, while reiterating its goal of keeping net working capital under 20 percent of revenue.
Market Divergence
The investment offensive drew a mixed response from analysts. J&T Banka initiated coverage with a buy recommendation, Barclays started with "Underweight," and RBC Capital Markets positioned itself neutrally with "Sector Perform." That divergence reflects differing views on how to weigh the elevated debt levels against the ambitious growth plans.
For the Dezamet contract specifically, analysts remain measured. The consensus rating is "Buy" with a price target in the range of roughly €31 to €35 — a level that suggests much of the positive news flow is already reflected in the share price. The stock trades at €17.78, just below that target range, having gained 32.10 percent over the past 30 trading days. It sits near its 100-day average of €17.75 and well above its 50-day average of €15.05.
The secondary article, citing Tuesday's trading, puts the share at €17.96 with a 30-day gain of 33.42 percent. Either way, the stock remains 50.20 percent below its 52-week high of €36.05 reached in January — a reminder of how much ground it lost before the recent run of contracts and investments restored investor confidence.
The Longer View
For investors, the Dezamet agreement is above all evidence of how deeply CSG has embedded itself in Polish defence supply chains. The combination of national framework agreements and European SAFE financing gives the company multi-year visibility on orders that extends well beyond any single contract. The recent flurry of activity — the Canadian stake, the German site, the board appointment, the Polish order — paints a picture of a group positioning itself across geographies and technologies at a moment when European defence spending is being reshaped by geopolitical realities. The question markets are now grappling with is whether the balance sheet can keep pace with the ambition.
Just as CSG must manage risks across its expanding operations, your business faces its own compliance obligations. Over 37,000 UK companies already use a free toolkit with 41 checklists covering fire safety, manual handling, first aid and lone working — everything you need for professional risk management. Get the free Health & Safety Toolkit
